Prenatal Human Milk Oligosaccharides (HMOs) in the Context of BMI, Gestational Weight Gain, and Lipid Profile—An Association Study in Pregnant Women with Overweight or Obesity
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202300533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Lukas Schönbacher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, Graz, 8036, Austria. Hauptthemen laut MEDLINE: Milk, Human, Gestational Weight Gain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund.
Abstract (Originalsprache)
Background
Human milk oligosaccharides (HMOs) are bioactive glycans first detected in human milk. Their presence in maternal blood during pregnancy suggests systemic functions. Dynamics and associations of the most abundant prenatal HMOs in relation to maternal BMI and serum lipids in a cohort of 87 pregnant women with either overweight or obesity are studied.
Methods
Serum HMOs (2’FL, 3’SL, 3’SLN, LDFT), serum lipids (total cholesterol, HDL, LDL, triglycerides), and BMI are measured at 15, 24, and 32 weeks of gestation.
Results
2’FL and LDFT are negatively correlated to pre‐pregnancy BMI and increase significantly slower between 15 and 24 weeks in highly obese women. Women without detectable increase of serum 2’FL (non‐secretors) show a less pronounced gestational weight gain and lower BMI in the third trimester as compared to women phenotype as secretors. Higher early‐pregnancy 2’FL is associated with high HDL and low triglycerides in pregnancy. On the other hand, higher 3’SL at 15 weeks is associated with higher triglycerides, LDL, and total cholesterol.
Conclusions
Higher early‐pregnancy 2’FL is associated with a cardioprotective lipid profile, whereas higher 3’SL is associated with an atherogenic lipid profile. Serum trajectories of 2’FL and LDFT in obese women suggest an obesity mediated delay of α‐1,2‐fucosylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, Graz, 8036, Austria.
- BioTechMed-Graz, Mozartgasse 12/II, Graz, 8010, Austria.
- Center for Medical Research, Medical University of Graz, Stiftingtalstraße 24, Graz, 8010, Austria.
- Institute of Human Movement Science, Sport and Health, University of Graz, Mozartgasse 14/I, Graz, 8010, Austria.
ORCID-Profile: Lukas Schönbacher, Evelyn Jantscher-Krenn
Förderung
- Austrian Science Fund
Zitieren
APA
Schönbacher, L., Treichler, C., Brandl, W., Köfeler, H. C., Fluhr, H., Jantscher-Krenn, E., & van Poppel, M. N. M. (2024). Prenatal Human Milk Oligosaccharides (HMOs) in the Context of BMI, Gestational Weight Gain, and Lipid Profile—An Association Study in Pregnant Women with Overweight or Obesity. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300533
Vancouver
Schönbacher L, Treichler C, Brandl W, Köfeler HC, Fluhr H, Jantscher-Krenn E, et al. Prenatal Human Milk Oligosaccharides (HMOs) in the Context of BMI, Gestational Weight Gain, and Lipid Profile—An Association Study in Pregnant Women with Overweight or Obesity. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300533
BibTeX
@article{Schnbacher2024,
author = {Schönbacher, Lukas and Treichler, Carmen and Brandl, Waltraud and Köfeler, Harald C and Fluhr, Herbert and Jantscher-Krenn, Evelyn and van Poppel, Mireille N M},
title = {Prenatal Human Milk Oligosaccharides (HMOs) in the Context of BMI, Gestational Weight Gain, and Lipid Profile—An Association Study in Pregnant Women with Overweight or Obesity},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202300533}
}
EUVIMED